Antifungal treatment administered by species on infection day 3.

*Other species includes: C. kefyr (nine isolates), C. famata (four isolates), C. rugosa (three isolates), C. utilis (two isolates) and one isolate each of C. fennica, C. fermentati, C. lipolytica, and Torulopsis spp.†multiple species include C. parapsilosis+C. glabrata (n = 30), C. tropicalis+C. glabrata (n = 21), C. krusei+C. glabrata (n = 8), C. dubliniensis+C. glabrata (n = 3), C. lusitaniae+C. glabrata (n = 4), other Candida spp.+C. glabrata (n = 3), unknown Candida spp.+C. glabrata (n = 3), C. guilliermondii+C. glabrata (n = 2), C. parapsilosis+C. krusei (n = 5), C. lusitaniae+C. krusei (n = 2), C. tropicalis+C. dubliniensis (n = 1), C. tropicalis+C. guilliermondii (n = 1), C. tropicalis+C. krusei (n = 4), other Candida spp.+C. guilliermondii (n = 1), unknown Candida spp.+C. dubliensis (n = 1), C. glabrata+C. krusei+C. lusitaniae (n = 1), C. dubliniensis+C.glabrata+C.guilliermondii (n = 1).§patients in this category were in a blinded clinical trial.‡Other combination therapies included lipid amphotericin B +5-fluorocytosine (n = 7), lipid amphotericin B+fluconazole (n = 10), amphotericin B deoxycholate+lipid amphotericin B (n = 1), amphotericin B deoxycholate+fluconazole (n = 2), echinocandins +5-fluorocytosine (n = 1), echinocandins+amphotericin B deoxycholate (n = 9), echinocandins+fluconazole (n = 1), echinocandins+itraconazole (n = 1), fluconazole+blinded (n = 1), fluconazole+voriconazole (n = 8).